The association between smoking cessation and glycaemic control in patients with type 2 diabetes: a THIN database cohort study

Deborah Lycett, L. Nichols, R. Ryan, A. Farley, A. Roalfe, M. Mohammed, L. Szatkowski, T. Coleman, R. Morris, A. Farmer, P. Aveyard

Research output: Contribution to journalArticle

36 Citations (Scopus)
34 Downloads (Pure)

Abstract

Background: Smoking increases the risk of developing type 2 diabetes. However, several population studies also show a higher risk in people 3–5 years after smoking cessation than in continuing smokers. After 10–12 years the risk equates to that of never-smokers. Small cohort studies suggest diabetes control deteriorates temporarily during the first year after quitting. We examined whether or not quitting smoking was associated with altered diabetes control in a population study, for how long this association persisted, and whether or not this association was mediated by weight change. Methods: We did a retrospective cohort study (Jan 1, 2005, to Dec 31, 2010) of adult smokers with type 2 diabetes using The Health Improvement Network (THIN), a large UK primary care database. We developed adjusted multilevel regression models to investigate the association between a quit event, smoking abstinence duration, change in HbA1c, and the mediating effect of weight change. Findings: 10 692 adult smokers with type 2 diabetes were included. 3131 (29%) quit smoking and remained abstinent for at least 1 year. After adjustment for potential confounders, HbA1c increased by 0·21% (95% CI 0·17–0·25; p
Original languageEnglish
Pages (from-to)423-430
Number of pages8
JournalThe Lancet Diabetes & Endocrinology
Volume3
Issue number6
DOIs
Publication statusPublished - Jun 2015

Fingerprint

Smoking Cessation
Type 2 Diabetes Mellitus
Cohort Studies
Smoking
Databases
Health
Weights and Measures
Population
Primary Health Care
Retrospective Studies

Bibliographical note

NOTICE: this is the author's version of a work that was accepted for publication in The Lancet Diabetes and Endocrinology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in http://www.thelancet.com/journals/landia/article/PIIS2213-8587(15)00082-0/abstract. © 2015, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/

Keywords

  • smoking cessation
  • diabetes
  • glycaemic control

Cite this

The association between smoking cessation and glycaemic control in patients with type 2 diabetes: a THIN database cohort study. / Lycett, Deborah; Nichols, L.; Ryan, R.; Farley, A.; Roalfe, A.; Mohammed, M.; Szatkowski, L.; Coleman, T.; Morris, R.; Farmer, A.; Aveyard, P.

In: The Lancet Diabetes & Endocrinology, Vol. 3, No. 6, 06.2015, p. 423-430.

Research output: Contribution to journalArticle

Lycett, D, Nichols, L, Ryan, R, Farley, A, Roalfe, A, Mohammed, M, Szatkowski, L, Coleman, T, Morris, R, Farmer, A & Aveyard, P 2015, 'The association between smoking cessation and glycaemic control in patients with type 2 diabetes: a THIN database cohort study' The Lancet Diabetes & Endocrinology, vol. 3, no. 6, pp. 423-430. https://doi.org/10.1016/S2213-8587(15)00082-0
Lycett, Deborah ; Nichols, L. ; Ryan, R. ; Farley, A. ; Roalfe, A. ; Mohammed, M. ; Szatkowski, L. ; Coleman, T. ; Morris, R. ; Farmer, A. ; Aveyard, P. / The association between smoking cessation and glycaemic control in patients with type 2 diabetes: a THIN database cohort study. In: The Lancet Diabetes & Endocrinology. 2015 ; Vol. 3, No. 6. pp. 423-430.
@article{69647b69f97c44e5be2834e42e724513,
title = "The association between smoking cessation and glycaemic control in patients with type 2 diabetes: a THIN database cohort study",
abstract = "Background: Smoking increases the risk of developing type 2 diabetes. However, several population studies also show a higher risk in people 3–5 years after smoking cessation than in continuing smokers. After 10–12 years the risk equates to that of never-smokers. Small cohort studies suggest diabetes control deteriorates temporarily during the first year after quitting. We examined whether or not quitting smoking was associated with altered diabetes control in a population study, for how long this association persisted, and whether or not this association was mediated by weight change. Methods: We did a retrospective cohort study (Jan 1, 2005, to Dec 31, 2010) of adult smokers with type 2 diabetes using The Health Improvement Network (THIN), a large UK primary care database. We developed adjusted multilevel regression models to investigate the association between a quit event, smoking abstinence duration, change in HbA1c, and the mediating effect of weight change. Findings: 10 692 adult smokers with type 2 diabetes were included. 3131 (29{\%}) quit smoking and remained abstinent for at least 1 year. After adjustment for potential confounders, HbA1c increased by 0·21{\%} (95{\%} CI 0·17–0·25; p",
keywords = "smoking cessation, diabetes, glycaemic control",
author = "Deborah Lycett and L. Nichols and R. Ryan and A. Farley and A. Roalfe and M. Mohammed and L. Szatkowski and T. Coleman and R. Morris and A. Farmer and P. Aveyard",
note = "NOTICE: this is the author's version of a work that was accepted for publication in The Lancet Diabetes and Endocrinology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in http://www.thelancet.com/journals/landia/article/PIIS2213-8587(15)00082-0/abstract. {\circledC} 2015, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/",
year = "2015",
month = "6",
doi = "10.1016/S2213-8587(15)00082-0",
language = "English",
volume = "3",
pages = "423--430",
journal = "The Lancet Diabetes and Endocrinology",
issn = "2213-8587",
publisher = "Elsevier",
number = "6",

}

TY - JOUR

T1 - The association between smoking cessation and glycaemic control in patients with type 2 diabetes: a THIN database cohort study

AU - Lycett, Deborah

AU - Nichols, L.

AU - Ryan, R.

AU - Farley, A.

AU - Roalfe, A.

AU - Mohammed, M.

AU - Szatkowski, L.

AU - Coleman, T.

AU - Morris, R.

AU - Farmer, A.

AU - Aveyard, P.

N1 - NOTICE: this is the author's version of a work that was accepted for publication in The Lancet Diabetes and Endocrinology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in http://www.thelancet.com/journals/landia/article/PIIS2213-8587(15)00082-0/abstract. © 2015, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/

PY - 2015/6

Y1 - 2015/6

N2 - Background: Smoking increases the risk of developing type 2 diabetes. However, several population studies also show a higher risk in people 3–5 years after smoking cessation than in continuing smokers. After 10–12 years the risk equates to that of never-smokers. Small cohort studies suggest diabetes control deteriorates temporarily during the first year after quitting. We examined whether or not quitting smoking was associated with altered diabetes control in a population study, for how long this association persisted, and whether or not this association was mediated by weight change. Methods: We did a retrospective cohort study (Jan 1, 2005, to Dec 31, 2010) of adult smokers with type 2 diabetes using The Health Improvement Network (THIN), a large UK primary care database. We developed adjusted multilevel regression models to investigate the association between a quit event, smoking abstinence duration, change in HbA1c, and the mediating effect of weight change. Findings: 10 692 adult smokers with type 2 diabetes were included. 3131 (29%) quit smoking and remained abstinent for at least 1 year. After adjustment for potential confounders, HbA1c increased by 0·21% (95% CI 0·17–0·25; p

AB - Background: Smoking increases the risk of developing type 2 diabetes. However, several population studies also show a higher risk in people 3–5 years after smoking cessation than in continuing smokers. After 10–12 years the risk equates to that of never-smokers. Small cohort studies suggest diabetes control deteriorates temporarily during the first year after quitting. We examined whether or not quitting smoking was associated with altered diabetes control in a population study, for how long this association persisted, and whether or not this association was mediated by weight change. Methods: We did a retrospective cohort study (Jan 1, 2005, to Dec 31, 2010) of adult smokers with type 2 diabetes using The Health Improvement Network (THIN), a large UK primary care database. We developed adjusted multilevel regression models to investigate the association between a quit event, smoking abstinence duration, change in HbA1c, and the mediating effect of weight change. Findings: 10 692 adult smokers with type 2 diabetes were included. 3131 (29%) quit smoking and remained abstinent for at least 1 year. After adjustment for potential confounders, HbA1c increased by 0·21% (95% CI 0·17–0·25; p

KW - smoking cessation

KW - diabetes

KW - glycaemic control

U2 - 10.1016/S2213-8587(15)00082-0

DO - 10.1016/S2213-8587(15)00082-0

M3 - Article

VL - 3

SP - 423

EP - 430

JO - The Lancet Diabetes and Endocrinology

JF - The Lancet Diabetes and Endocrinology

SN - 2213-8587

IS - 6

ER -